secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001006837-23-000127
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE Q3 rev $375M (-11% YoY), Adj EBITDA $22.1M (+35%); extends note maturity to 2025
--------------------------------------------------------------------------------

- Net loss $7.3M ($0.09/sh) flat YoY; Adj EBITDA $22.1M vs $16.4M (+34.8%).
- Infrastructure DBM Global rev $369.3M (-10.5%), Adj EBITDA margin 8.3% (+170bps), backlog $1.3B.
- Spectrum rev $5.4M (-41%) due to Azteca closure; exploring datacasting partnerships with HPE and PBS.
- Life Sciences rev $0.6M, loss narrows; MediBeacon continues FDA approval process.
- Post-quarter: extended $69.7M secured notes maturity to Aug 2025; INNOVATE to use sale proceeds for repayment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683723000127/0001006837-23-000127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683723000127/hchc-20231109.htm
  HTML page:      https://secwatch.observer/filing/0001006837-23-000127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer